| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755268A1 Compositions and methods for gene therapy to treat disease |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0755258A1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/29/1997 | EP0708671A4 Drug delivery |
| 01/29/1997 | EP0477290B1 Methods, compositions and devices for growing cells |
| 01/29/1997 | CN1141594A Method for identifying individuals suffering from cellular abnormality |
| 01/28/1997 | US5597895 Inhibiting the expression of hiv virus |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1997002347A1 A human map kinase homolog |
| 01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
| 01/23/1997 | WO1997002049A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | WO1997002048A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | WO1997002047A1 Gene preparations |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | WO1996025947A3 Induction of e-selectin for targetting therapeutic agents |
| 01/23/1997 | CA2226417A1 Neuronal progenitor cells and uses thereof |
| 01/23/1997 | CA2226011A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
| 01/22/1997 | EP0754237A1 An adenovirus supervector system |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0696191B1 Particulate vector and pharmaceutical composition containing such vector |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
| 01/21/1997 | US5595911 Isolation of a cDNA encoding a protein tyrosine phosphatase which localizes to focal adhesions |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/16/1997 | WO1997001635A1 Bax omega protein and methods |
| 01/16/1997 | WO1997001634A2 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 01/16/1997 | WO1997001577A1 Ion channel |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001358A1 Tissue specific viral vectors |
| 01/16/1997 | WO1997001357A1 Encapsulated cells producing viral particles |
| 01/16/1997 | WO1996037610A3 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders |
| 01/16/1997 | WO1996027677A3 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 01/16/1997 | CA2224701A1 Bax omega protein and methods |
| 01/16/1997 | CA2222559A1 Encapsulated cells producing viral particles |
| 01/16/1997 | CA2222457A1 Tissue specific viral vectors |
| 01/16/1997 | CA2221294A1 Tetradotoxin insensitive sodium channel |
| 01/15/1997 | EP0753580A2 Cell-specific gene therapy, using the tissue inhibitor of metalloproteinase-3 promoter |
| 01/15/1997 | EP0753574A1 Methods and compositions for obtaining ex vivo human progenitor cell expansion |
| 01/15/1997 | EP0753312A1 Arteriosclerosis remedy |
| 01/15/1997 | EP0753069A1 Gene delivery fusion proteins |
| 01/15/1997 | EP0753068A1 Ligands added to adenovirus fiber |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0752882A1 Treatment for juvenile diabetes |
| 01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/14/1997 | US5594122 Bind to conserved regions of human immunodeficiency virus genetic material to prevent expression thereof |
| 01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| 01/14/1997 | US5593974 Localized oligonucleotide therapy |
| 01/14/1997 | US5593972 Genetic immunization |
| 01/13/1997 | CA2181022A1 Cell-specific gene therapy using a novel promoter for tissue inhibitor of metalloproteinase-3 |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000954A1 C-cam expression constructs and their application in cancer therapy |
| 01/09/1997 | WO1997000953A1 Aortic preferentially-expressed gene apeg-1 and uses thereof |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000950A1 New immunoregulatory protein lst-1 |
| 01/09/1997 | WO1997000947A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | CA2226085A1 Aortic preferentially-expressed gene and uses thereof |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/08/1997 | EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752002A1 Inhibition of arterial smooth muscle cell proliferation |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751999A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
| 01/08/1997 | EP0751994A1 C-terminally truncated cftr genes and proteins |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751987A1 Genetically modified cells for use in transplantation |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |